Table 1 |
|
| Description of the study population | |
| Clinical & pathological characteristics | No. |
| Mean (s.d.) Age (years) | 66 (±12) |
| Sex | |
| Male | 68 (58) |
| Female | 49 (42) |
| Mean (s.d.) follow-up (months) | 57 (±25) |
| Median follow-up (range) | 61 (5-113) |
| Tumor stage | |
| T1 | 3 (2) |
| T2 | 9 (8) |
| T3 | 82 (69) |
| T4 | 13 (11) |
| Node stage | |
| N0 | 78 (67) |
| N1 | 39 (33) |
| Mean (s.d.) number of LN harvested | 27,5 (±14) |
| Microsatellite instability status | |
| Positive | 10 (9) |
| Negative | 107 (91) |
| Number of CD3+ lymphocytes/mm² (TMA) | |
| Mean | 612 (±481) |
| Range | 21-3014 |
LN lymph node.
The values shown in brackets are percentages, unless otherwise indicated.
Allard et al. Diagnostic Pathology 2012 7:156 doi:10.1186/1746-1596-7-156
